Walgreens has published a study in the journal Population Health Management that shows the company’s multi-faceted medication adherence program produced 3 percent greater medication adherence and ...

Forbes contributors publish independent expert analyses and insights. Bruce Japsen writes about healthcare business and policy. Walgreens Boots Alliance will expand the number of safe medication ...

The Route 66 Walgreens has a new addition in its pharmacy: a safe mediation disposal kiosk. Since launching the safe mediation disposal program in 2016, Walgreens has collected more than 270 tons of ...

Johns Hopkins Medicine (JHM) and Walgreens (NYSE, NASDAQ:WAG) today announced they have entered into a wide-ranging agreement designed to promote collaboration on population-based research and to ...

Digital patient engagement company HealthPrize Technologies has partnered with Walgreens to offer its medication adherence platform on the drugstore chain’s website. The program will be offered to ...

“Walgreens has taken an important first step to curb the misuse of medications throughout the country and continues to make progress in offering easy and convenient medication disposal,” said Richard ...

A recent study evaluating the use of non-infused biologics in patients diagnosed with rheumatoid arthritis demonstrated that patients who are adherent to their non-infused RA biologic medication are ...

SAN DIEGO — CVS and Walgreens are putting limits on how much children's medicine you can buy. This comes as cases of RSV, flu and COVID have driven demand and left shelves across the country scarce.

Walgreens Boots Alliance will strengthen its training for pharmacists after a woman was denied a miscarriage medication in Arizona because of a pharmacist’s personal objection, according to Bloomberg.

CVS and Walgreens said they’ve received certification to dispense mifepristone, a pill that’s part of a regimen for medication abortion, and will start making the medicine available in a limited ...

Walgreens Boots Alliance is currently trading at a cheap valuation with a non-GAAP Fwd P/E of 5.5x. The company is an integrated healthcare and pharmacy retailer with a strong presence in the US, ...